Test Price
2,800 AEDโ Home Collection Available
DARS Gene Hypomyelination with Brainstem and Spinal Cord Involvement and Leg Spasticity (Genetic Test) in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
99.9% Diagnostic Accuracy via ISO-Certified Next-Generation Sequencing. Premium VIP home collection with temperature-controlled cold-chain logistics (8 AMโ11 PM). Complimentary post-test telehealth interpretation with a DHA-licensed genetic specialist. Instant insurance coverage verification โ send your Emirates ID via WhatsApp to +971 54 548 8731.
- Accuracy: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing.
- Logistics: Paid hospital-grade home collection, ISO certified cold-chain transport.
- Clinical Support: Free telehealth consultation with a DHA-licensed consultant medical geneticist.
- Insurance: Instant eligibility check โ send Emirates ID via WhatsApp to +971 54 548 8731.
Test Overview & Methodology
This Next-Generation Sequencing (NGS) assay analyzes the entire DARS gene, including all exons, intron-exon boundaries, and splice sites, with concurrent copy number variation (CNV) detection. It is the most comprehensive molecular diagnostic tool for hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) available in the UAE. The test delivers a diagnostic yield of 99.9% for DARS variants, surpassing traditional Sanger sequencing by capturing deep intronic mutations and CNVs.
NGS vs Sanger Sequencing Comparison
| Feature | Our DARS NGS Test | Sanger Sequencing |
|---|---|---|
| Method | Next-Generation Sequencing โ full gene & CNV | Targeted sequencing of known exons only |
| Coverage | All exons, intron-exon boundaries, splice sites | Limited to pre-selected regions |
| Turnaround Time | 3โ4 weeks | 4โ6 weeks |
| Diagnostic Yield | 99.9% for DARS variants | ~95% (misses deep intronic and CNV) |
| Price | 2800 AED | Varies, often >3000 AED |
Physician Insight & Safety Protocols
"A DARS gene mutation result must always be interpreted within the full clinical context. As a consultant medical geneticist, I counsel families that this test provides clarity for targeted management and recurrence risk assessment. No single genetic test replaces a comprehensive neurological examination and metabolic workup." โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.
Advisory: Medication Continuation
โ ๏ธ Do not discontinue any prescribed medication (e.g., antispasticity drugs, anticonvulsants) without direct consultation with your treating physician. Abrupt cessation may worsen symptoms or trigger withdrawal effects.
Exclusion Criteria & Red Flags
- Patients under 18 years require legal guardianโs informed consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Recent blood transfusion within 2 weeks (may affect DNA purity).
- Emergency Red Flags: If the patient develops acute respiratory distress, rapid worsening of spasticity with loss of ambulation, or new-onset seizures, seek immediate emergency care โ do not wait for genetic test results.
Patient FAQ & Clinical Guidance
1. What is the DARS gene test, and why is it important for hypomyelination with brainstem involvement?
The DARS Genetic Test detects mutations in the DARS gene, confirming hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL). This high-resolution NGS analysis identifies disease-causing variants, enabling precise neurological management and recurrence risk assessment for families. The test is performed on blood or FTA cards using ISO-certified protocols.
2. How should I prepare for the DARS gene test, and what samples are required?
No special fasting is required; a simple blood draw, extracted DNA, or FTA card blood spot is accepted following prior genetic counseling. A certified phlebotomist will collect the sample at your home via VIP mobile phlebotomy, and a genetic counsellor will review the pedigree chart to ensure accurate interpretation. Results are available in 3โ4 weeks.
3. Is this test covered by insurance in the UAE, and how do I verify?
Many UAE insurance plans cover genetic testing for neurological disorders; our team directly verifies your coverage via WhatsApp. Send your Emirates ID and medical referral to +971 54 548 8731, and we will respond within minutes with approval status and any out-of-pocket details.
4. What do the results mean for my family planning?
A positive result confirms an autosomal recessive condition. We offer complimentary genetic counseling to discuss carrier testing for at-risk relatives and reproductive options including preimplantation genetic diagnosis (PGD). All counseling is confidential and respectful of cultural sensitivities.
UAE Regulatory & Data Privacy Adherence
This service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and stored within UAE sovereign health clouds. Informed consent for minors is obtained per Federal Decree-Law No. 4 of 2016 on Medical Liability. Laboratory operations are accredited under ISO 9001:2015.
Clinical & Logistical Metadata
| Test Name | DARS Gene Sequencing & CNV Analysis for Hypomyelination with Brainstem and Spinal Cord Involvement and Leg Spasticity (HBSL) |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3โ5 ml in EDTA), extracted DNA, or FTA card blood spot |
| Methodology Used | Next-Generation Sequencing (Illumina platform) with CNV analysis |
| ICD-10-CM Code | G37.8 |
| LOINC Code | 94101-2 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians